Renowned Madagascar Scientist, Explorer and Mentor Named Winner of World's Leading Animal Conservation Award
Throughout his years of research and expeditions, René de Roland has discovered several new species, led the establishment of four national protected areas and developed community-focused conservation programs. Since 2004, he has been the National Director of The Peregrine Fund's Madagascar Program, where he oversees a team of 48 Malagasy conservationists working to conserve wildlife and landscapes in his homeland.
René de Roland is the tenth Winner of the Indianapolis Prize.
"Dr. René de Roland's community-based models and decades of research have not only alleviated human-wildlife conflicts—they have also helped to conserve Madagascar's unique and wonderful animals and ecosystems. He is dedicated, resourceful and a fierce advocate for Madagascar wildlife, and I'm proud to announce him as this year's Indianapolis Prize Winner," said Dr. Rob Shumaker, President and CEO of the Indianapolis Zoo.
René de Roland's contribution to the discovery of a variety of species is substantial, including the rediscovery of the Madagascar pochard, a rare duck thought to be extinct since the 1990s. He and his team rediscovered the species during a challenging expedition to a remote area of northern Madagascar in 2006. René de Roland has also contributed to the discovery of two previously undescribed lemur species in northern Madagascar. Due to his extensive impact on biodiversity conservation, scientists named a newly described wolf spider, Katableps lilyarisoni, after René de Roland in 2021. Most recently, during a 2022 expedition, René de Roland led a team to the rediscovery of the Dusky tetraka, a small songbird that had eluded ornithologists for 20 years.
"I am honored to receive this prestigious award from the Indianapolis Zoo," said René de Roland. "My work is inspired by my pride for my country's biodiversity and my love for its wonderful people."
René de Roland has led the creation of four national protected areas in Madagascar totaling over 1,500 square miles, including rainforests, dry forests, wetlands, mangroves and savannahs. These efforts not only preserve endemic Madagascar species under threat but also improve the lives of local people, with whom René de Roland works to manage these areas and sustainably leverage their resources.
Through his work, René de Roland has also helped to shape the next generation of Malagasy conservationists. His legacy extends to more than 100 students at local Madagascar universities, with his mentees earning 90 master's degrees and 16 doctoral degrees.
"The Peregrine Fund is tremendously proud of Lily, whose commitment to science, conservation and his community inspires us all," said Chris N. Parish, President and CEO of The Peregrine Fund. "We are beyond excited that the Indianapolis Prize is recognizing him for his research, mentorship and decades of work in the conservation profession."
René de Roland earned his master's degree, doctoral degree and professorship at the University of Antananarivo in Madagascar. He joined The Peregrine Fund as a student in 1992 to study Madagascar's imperiled raptors.
Established by the Indianapolis Zoo in 2004, the Indianapolis Prize recognizes and rewards the world's preeminent animal conservationists who have achieved major victories in advancing the sustainability of an animal species or group of species. Winners receive $250,000, which is the largest individual monetary award given in the animal conservation field.
René de Roland, the 2025 Indianapolis Prize DeHaan Finalists and the 2025 Indianapolis Prize Emerging Conservationist Award Winner will be celebrated at the Indianapolis Prize Gala on Sept. 27, 2025, presented by Cummins Inc., in downtown Indianapolis.
For additional media assets for the 2025 Indianapolis Prize, click here. To learn more about the previous Indianapolis Prize Winners, visit IndianapolisPrize.org.
About the Indianapolis Prize
The Indianapolis Prize recognizes and rewards conservationists who have achieved major victories in advancing the sustainability of an animal species or group of species. The Emerging Conservationist Award, a newly established accolade in 2023, is given to a conservationist aged 40 or younger. Since 2004, the Indianapolis Prize has awarded more than $7.5 million in unrestricted cash awards, advancing the work of conservation scientists through financial support and public awareness. The Indianapolis Prize is a conservation initiative of the Indianapolis Zoo.
Connect with the Prize on Facebook, X, Instagram and indianapolisprize.org.
View original content to download multimedia:https://www.prnewswire.com/news-releases/renowned-madagascar-scientist-explorer-and-mentor-named-winner-of-worlds-leading-animal-conservation-award-302451258.html
SOURCE Indianapolis Zoo
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2025/13/c6098.html
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
07-08-2025
- Yahoo
Genome BC Funds Research into the Respiratory Fallout of Wildfires
VANCOUVER, BC, Aug. 6, 2025 /CNW/ - British Columbians know the stark realities of climate change, as wildfires surge across the province. Over a million hectares burned across BC in 2024, blanketing communities in thick smoke and dramatically increasing the number of hazy, lung-choking days. As summer becomes a season of smoke, this escalating environmental challenge also has a hidden, insidious impact: a profound and lasting toll on our respiratory health. Wildfire smoke is more than just an inconvenience; it's a dangerous cocktail of particulate matter that infiltrates our lungs and bodies, exacerbating existing conditions and potentially triggering new ones. The costs are staggering, both in human lives and healthcare dollars, with Health Canada estimating up to 240 deaths and $1.8 billion in annual costs due to short-term health effects alone. In response to this challenge, Genome BC is funding three research projects that will delve into the genetic-level impacts of wildfire smoke exposure. "These projects are specifically designed to uncover what makes our vulnerable populations – from newborns to those with chronic lung conditions – more susceptible to wildfire-related respiratory issues," said Suzanne Gill, Genome BC's President and CEO. "We hope this knowledge can both inform treatment and care within our healthcare system and reduce the overall economic toll of wildfires." PROJECT 1: Wildfire Exposure and Early Childhood Health The next generation of British Columbians could be feeling the effects of wildfires before they even take their first breath. This project uses a holistic approach to study the impact of disaster exposure during pregnancy, including if it can have lasting effects on how genes are expressed in developing children. This may increase the risk of respiratory diagnoses such as asthma, bronchitis, wheezing, hives, eczema and other allergic reactions. Lead Researcher, Dr. Michael Kobor of the University of British Columbia believes the results can inform public health policies about respiratory health, especially vulnerable groups such as infants and pregnant people. "With this research, we aim to better our understanding of the impacts of prenatal wildfire disaster exposure on the next generation," he said. "Early-life environments can have a lasting impact on people throughout the course of their lives, including on their health outcomes. We hope this work will help shape healthy futures for children as global temperatures rise and wildfires become increasingly common." PROJECT 2: How Wildfire Smoke Affects People with Chronic Obstructive Pulmonary Disease (COPD) For the over 2 million Canadians living with Chronic Obstructive Pulmonary Disease (COPD), wildfire smoke presents a particularly grave threat. COPD is already the leading cause of hospitalization in Canada, costing our healthcare system an estimated $1.5 billion annually. Wildfire smoke can significantly worsen symptoms and lead to severe complications for COPD patients. Dr. Graeme Koelwyn from Simon Fraser University and and Dr. Don Sin from the University of British Columbia are studying the genomic changes in innate immune cells — our first line of defense against inhaled particles — of COPD patients. Their research aims to understand how these immune cells respond to wildfire smoke in patients at the genetic level as symptoms become worse, and to identify effective treatments. "This information is critical to develop disease management and exposure mitigation strategies for people living with COPD," Dr. Koelwyn said, "especially in this time of increasing societal and financial burden within our changing world and environment." PROJECT 3: How Wildfire Smoke and Aeroallergens Affect Lung Health Dr. Emilia Lim and Dr. Min Hyung Ryu from the University of British Columbia are focusing on airborne allergens (aeroallergens) triggered by the increase of atmospheric carbon dioxide and high temperatures that happen when there are frequent wildfires. These situations also tend to prolong allergy seasons. Our bodies generate an immune response to protect us when aeroallergens enter our lungs. "Aeroallergens are harmful to everyone, but people with lung conditions such as asthma, COPD and lung cancer survivors are at higher risk," because their immune systems are theoretically less robust, Dr. Lim explains. "It's important to know how these groups are affected differently." The researchers want to understand the links between our individual genetic differences and environmental triggers. Dr. Ryu noted, "identifying populations that are susceptible to these changes can help us find better ways to prevent and treat respiratory diseases." The Value of Proactive Research The escalating financial burden of wildfire recovery underscores the urgent need for proactive strategies. These three projects exemplify how genomics research is providing critical insights into the complex interplay between our environment and our health. "With our proximity to wildfires and access to interdisciplinary teams, Canadian researchers are uniquely equipped to tackle these questions first-hand," said Gill. "The fundamental knowledge gained will lay the groundwork for better policy decisions and more efficient treatments in the future. Any breakthroughs in respiratory health or disease prevention will translate into economic benefits for British Columbians and beyond." About Genome British Columbia: Genome BC is a not-for-profit organization that has advanced genomics research and innovation for 25 years, growing a world-class life sciences sector in BC and delivering sustainable benefits for British Columbia, Canada and beyond. Genome BC has attracted over $1.1 billion in direct co-investment to the province, which has contributed to funding more than 600 genomics research and innovation projects. These initiatives enhance healthcare and address environmental and natural resource challenges, improving the lives of British Columbians. Genome BC also integrates genomics into society by supporting responsible research and innovation and fostering an understanding and appreciation of the life sciences among educators, students and the public. SOURCE Genome British Columbia View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
01-08-2025
- Yahoo
MEDIA ADVISORY: Baycrest Experts Available During AAIC® 2025 in Toronto
TORONTO, July 25, 2025 /CNW/ - From July 27 to 31, Toronto hosts the Alzheimer's Association International Conference® 2025 (AAIC®), the world's largest forum for dementia research. With Canada in the spotlight, Baycrest is recognized globally for its leadership in aging and brain health. Our scientists and experts are participating in the conference and available to support your coverage. This international gathering offers a timely opportunity to explore the growing impact of dementia on families, economies and health care systems, along with the latest advances in prevention, care, treatment and research. Dr. Howard ChertkowScientific Director, Baycrest's Kimel Family Centre for Brain Health & WellnessScientific Director, Canadian Consortium on Neurodegeneration in Aging (CCNA)Dr. Chertkow is a member of the AAIC Scientific Program Committee and one of Canada's most respected dementia researchers. He is available to speak on topics including dementia detection, prevention, treatment and Canada's role in the global research landscape. More Baycrest Experts You Can Speak With Dr. Adriana Shnall, Program Director, Baycrest Koschitzky Centre for Innovations in Caregiving, can speak to innovative tools supporting dementia caregivers, including those in rural and underserved communities. At AAIC, she is co-presenting on the use of virtual reality, AI and other strategies to better support families in community and long-term care settings. Dr. Allison Sekuler, President & Chief Scientist, Baycrest Academy for Research and Education is available to speak on the rising prevalence of dementia in Canada and its impact on individuals, families and the healthcare system. Dr. Nicole Anderson, Associate Scientific Director, Baycrest's Kimel Family Centre for Brain Health & Wellness, can discuss the latest in dementia prevention research, including evidence that nearly half of all cases may be preventable. Baycrest combines world-class care with cutting-edge research to help shape the future of aging and brain health. If you are working on AAIC-related coverage or broader dementia stories, our experts are available for interviews throughout the conference. Throughout the week, we will share updates with media highlighting key topics, research developments and expert perspectives from Baycrest. Please contact Natasha Nacevski-Laird, Media Relations Specialist at Baycrest, to schedule an interview. About Baycrest At Baycrest, our vision is a world where every older person lives with purpose, fulfilment and dignity. Baycrest is a global leader in aging and brain health innovation, with over 105 years of expertise in seniors' care and cutting-edge research. Baycrest has been Designated with Exemplary Status by Accreditation Canada, and drives industry-leading care and safety outcomes. As the home of the Centre for Aging + Brain Health Innovation (CABHI) powered by Baycrest, the Baycrest Academy for Research and Education (BARE) and the Canadian Consortium on Neurodegeneration in Aging, Baycrest is at the forefront of dementia research. Affiliated with the University of Toronto, Baycrest's training programs shape the future of care globally, while Baycrest Global Solutions extends its expertise to senior living and healthcare internationally. For more information, visit: SOURCE Baycrest View original content to download multimedia:
Miami Herald
30-07-2025
- Miami Herald
Island creature — with vibrant orange belly — is a new species in Madagascar
Under the cover of darkness, a group of researchers searched the northern forests of Madagascar for a small lizard. Moving between burnt trees in a densely packed forest, they noticed the little animals 'sleeping … on twigs or small branches,' and stopped for a closer look. The animals belong to a genus of geckos called Lygodactylus, or dwarf geckos, and were found to belong to species new to science, according to a study published July 23 in the peer-reviewed journal Zootaxa. Researchers found one of these new species in Baie De Baly National Park, a peninsula on Madagascar's northwestern coast, according to the study. The tail of the gecko is slightly longer than the rest of the body — 1.1 inches long compared to a body length of 1 inch – accounting for half of the animal's total size, researchers said. The species, named Lygodactylus arnei, can be distinguished from other dwarf geckos by the vibrant orange color on the bottom of its tail, stretching to its belly and sometimes its chest, according to the study. The rest of its underside is white, researchers said, while its back is slightly blue-gray in color with bands of white and brown coloring. Overall, the gecko is a bit wider than other species and has 'relatively large' eyes for its head, according to the study. 'The species name is a patronym for the wildlife photographer and gecko specialist Arne Hartig, in recognition for his contributions to the exploration of Madagascar's gecko fauna and the important support he provided for this study by making photos and information from his previous Namoroka expeditions available,' researchers said. The Arne Hartig dwarf gecko is arboreal, meaning it spends most of its life in trees, in a generally dry area, according to the study. In Baie de Baly National Park, a large number of trees were partially burnt about a year before the new species was found, according to the study, but while the smaller trees were dead and the leaf litter was scorched, many of the larger trees appeared in good condition. The new species was also found in two other regions of Madagascar, both within about 30 miles of the national park, researchers said. 'In the Tsiombikibo Forest, L. arnei has been found in a forested area where trees are relatively small and densely implanted, and where a relatively thin layer of leaf litter mostly rests on a bed of almost pure white sand,' researchers said. 'In Namoroka, this species has been more frequently found on tree trunks – or at their base, close to the leaf litter – growing in the border of the Tsingy karstic formation.' The 'tsingys' refers to an area of northwestern Madagascar covered with towering rock formations that look like shards of stone placed vertically in the ground. The name translates to 'where one cannot walk barefoot' in Malagasy, and the region provides a home to a high diversity of lizards, including other dwarf geckos. The Arne Hartig dwarf gecko was one of three new species found during the same 2023 expedition included in the study. The research team included Miguel Vences, Cecilia Herrmann, Malte Multzsch, Sven Gippner, Delina Razafimanafo, Ny Ando Rahagalala, Sandratra Rakotomanga, Andolalao Rakotoarison, Frank Glaw and Aurélien Miralles.
